0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global β-nicotinamide Riboside Chloride Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-10M16941
Home | Market Reports | Health| Nutrition| Vitamins & Supplements
Global β nicotinamide Riboside Chloride Market Research Report 2024
BUY CHAPTERS

Global β-nicotinamide Riboside Chloride Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-10M16941
Report
November 2025
Pages:142
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

β-nicotinamide Riboside Chloride Market

The global β-nicotinamide Riboside Chloride market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Health Products accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
β-nicotinamide Riboside Chloride leading manufacturers including GeneHarbor, Cayman Chemical, Stanford Advanced Materials, Hangzhou Longshine Bio-Tech, Haihang Industry, Qingdao Hong Jin Chemical, Jinan Qinmu Fine chemical, Shanghai Theorem Chemical Technology, etc., dominate supply; the top five capture approximately % of global revenue, with GeneHarbor leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global β-nicotinamide Riboside Chloride market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of β-nicotinamide Riboside Chloride Market Report

Report Metric Details
Report Name β-nicotinamide Riboside Chloride Market
Segment by Type
  • ≥99% Purity
  • ≥98% Purity
  • ≥97% Purity
  • Others
Segment by Application
  • Health Products
  • Pharmaceutical Intermediates
  • Cosmetic Additives
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GeneHarbor, Cayman Chemical, Stanford Advanced Materials, Hangzhou Longshine Bio-Tech, Haihang Industry, Qingdao Hong Jin Chemical, Jinan Qinmu Fine chemical, Shanghai Theorem Chemical Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the β-nicotinamide Riboside Chloride study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
  • Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
  • Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the β-nicotinamide Riboside Chloride Market report?

Ans: The main players in the β-nicotinamide Riboside Chloride Market are GeneHarbor, Cayman Chemical, Stanford Advanced Materials, Hangzhou Longshine Bio-Tech, Haihang Industry, Qingdao Hong Jin Chemical, Jinan Qinmu Fine chemical, Shanghai Theorem Chemical Technology

What are the Application segmentation covered in the β-nicotinamide Riboside Chloride Market report?

Ans: The Applications covered in the β-nicotinamide Riboside Chloride Market report are Health Products, Pharmaceutical Intermediates, Cosmetic Additives, Others

What are the Type segmentation covered in the β-nicotinamide Riboside Chloride Market report?

Ans: The Types covered in the β-nicotinamide Riboside Chloride Market report are ≥99% Purity, ≥98% Purity, ≥97% Purity, Others

1 Study Coverage
1.1 Introduction to β-nicotinamide Riboside Chloride: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global β-nicotinamide Riboside Chloride Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 ≥99% Purity
1.2.3 ≥98% Purity
1.2.4 ≥97% Purity
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global β-nicotinamide Riboside Chloride Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Health Products
1.3.3 Pharmaceutical Intermediates
1.3.4 Cosmetic Additives
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global β-nicotinamide Riboside Chloride Revenue Estimates and Forecasts 2020-2031
2.2 Global β-nicotinamide Riboside Chloride Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global β-nicotinamide Riboside Chloride Sales Estimates and Forecasts 2020-2031
2.4 Global β-nicotinamide Riboside Chloride Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global β-nicotinamide Riboside Chloride Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global β-nicotinamide Riboside Chloride Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global β-nicotinamide Riboside Chloride Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 ≥99% Purity Market Size by Manufacturers
4.5.2 ≥98% Purity Market Size by Manufacturers
4.5.3 ≥97% Purity Market Size by Manufacturers
4.5.4 Others Market Size by Manufacturers
4.6 Global β-nicotinamide Riboside Chloride Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global β-nicotinamide Riboside Chloride Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global β-nicotinamide Riboside Chloride Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global β-nicotinamide Riboside Chloride Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global β-nicotinamide Riboside Chloride Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America β-nicotinamide Riboside Chloride Sales and Revenue by Type (2020-2031)
7.4 North America β-nicotinamide Riboside Chloride Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America β-nicotinamide Riboside Chloride Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe β-nicotinamide Riboside Chloride Sales and Revenue by Type (2020-2031)
8.4 Europe β-nicotinamide Riboside Chloride Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe β-nicotinamide Riboside Chloride Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific β-nicotinamide Riboside Chloride Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific β-nicotinamide Riboside Chloride Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific β-nicotinamide Riboside Chloride Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America β-nicotinamide Riboside Chloride Sales and Revenue by Type (2020-2031)
10.4 Central and South America β-nicotinamide Riboside Chloride Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America β-nicotinamide Riboside Chloride Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa β-nicotinamide Riboside Chloride Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa β-nicotinamide Riboside Chloride Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa β-nicotinamide Riboside Chloride Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 GeneHarbor
12.1.1 GeneHarbor Corporation Information
12.1.2 GeneHarbor Business Overview
12.1.3 GeneHarbor β-nicotinamide Riboside Chloride Product Models, Descriptions and Specifications
12.1.4 GeneHarbor β-nicotinamide Riboside Chloride Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 GeneHarbor β-nicotinamide Riboside Chloride Sales by Product in 2024
12.1.6 GeneHarbor β-nicotinamide Riboside Chloride Sales by Application in 2024
12.1.7 GeneHarbor β-nicotinamide Riboside Chloride Sales by Geographic Area in 2024
12.1.8 GeneHarbor β-nicotinamide Riboside Chloride SWOT Analysis
12.1.9 GeneHarbor Recent Developments
12.2 Cayman Chemical
12.2.1 Cayman Chemical Corporation Information
12.2.2 Cayman Chemical Business Overview
12.2.3 Cayman Chemical β-nicotinamide Riboside Chloride Product Models, Descriptions and Specifications
12.2.4 Cayman Chemical β-nicotinamide Riboside Chloride Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Cayman Chemical β-nicotinamide Riboside Chloride Sales by Product in 2024
12.2.6 Cayman Chemical β-nicotinamide Riboside Chloride Sales by Application in 2024
12.2.7 Cayman Chemical β-nicotinamide Riboside Chloride Sales by Geographic Area in 2024
12.2.8 Cayman Chemical β-nicotinamide Riboside Chloride SWOT Analysis
12.2.9 Cayman Chemical Recent Developments
12.3 Stanford Advanced Materials
12.3.1 Stanford Advanced Materials Corporation Information
12.3.2 Stanford Advanced Materials Business Overview
12.3.3 Stanford Advanced Materials β-nicotinamide Riboside Chloride Product Models, Descriptions and Specifications
12.3.4 Stanford Advanced Materials β-nicotinamide Riboside Chloride Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Stanford Advanced Materials β-nicotinamide Riboside Chloride Sales by Product in 2024
12.3.6 Stanford Advanced Materials β-nicotinamide Riboside Chloride Sales by Application in 2024
12.3.7 Stanford Advanced Materials β-nicotinamide Riboside Chloride Sales by Geographic Area in 2024
12.3.8 Stanford Advanced Materials β-nicotinamide Riboside Chloride SWOT Analysis
12.3.9 Stanford Advanced Materials Recent Developments
12.4 Hangzhou Longshine Bio-Tech
12.4.1 Hangzhou Longshine Bio-Tech Corporation Information
12.4.2 Hangzhou Longshine Bio-Tech Business Overview
12.4.3 Hangzhou Longshine Bio-Tech β-nicotinamide Riboside Chloride Product Models, Descriptions and Specifications
12.4.4 Hangzhou Longshine Bio-Tech β-nicotinamide Riboside Chloride Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Hangzhou Longshine Bio-Tech β-nicotinamide Riboside Chloride Sales by Product in 2024
12.4.6 Hangzhou Longshine Bio-Tech β-nicotinamide Riboside Chloride Sales by Application in 2024
12.4.7 Hangzhou Longshine Bio-Tech β-nicotinamide Riboside Chloride Sales by Geographic Area in 2024
12.4.8 Hangzhou Longshine Bio-Tech β-nicotinamide Riboside Chloride SWOT Analysis
12.4.9 Hangzhou Longshine Bio-Tech Recent Developments
12.5 Haihang Industry
12.5.1 Haihang Industry Corporation Information
12.5.2 Haihang Industry Business Overview
12.5.3 Haihang Industry β-nicotinamide Riboside Chloride Product Models, Descriptions and Specifications
12.5.4 Haihang Industry β-nicotinamide Riboside Chloride Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Haihang Industry β-nicotinamide Riboside Chloride Sales by Product in 2024
12.5.6 Haihang Industry β-nicotinamide Riboside Chloride Sales by Application in 2024
12.5.7 Haihang Industry β-nicotinamide Riboside Chloride Sales by Geographic Area in 2024
12.5.8 Haihang Industry β-nicotinamide Riboside Chloride SWOT Analysis
12.5.9 Haihang Industry Recent Developments
12.6 Qingdao Hong Jin Chemical
12.6.1 Qingdao Hong Jin Chemical Corporation Information
12.6.2 Qingdao Hong Jin Chemical Business Overview
12.6.3 Qingdao Hong Jin Chemical β-nicotinamide Riboside Chloride Product Models, Descriptions and Specifications
12.6.4 Qingdao Hong Jin Chemical β-nicotinamide Riboside Chloride Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Qingdao Hong Jin Chemical Recent Developments
12.7 Jinan Qinmu Fine chemical
12.7.1 Jinan Qinmu Fine chemical Corporation Information
12.7.2 Jinan Qinmu Fine chemical Business Overview
12.7.3 Jinan Qinmu Fine chemical β-nicotinamide Riboside Chloride Product Models, Descriptions and Specifications
12.7.4 Jinan Qinmu Fine chemical β-nicotinamide Riboside Chloride Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Jinan Qinmu Fine chemical Recent Developments
12.8 Shanghai Theorem Chemical Technology
12.8.1 Shanghai Theorem Chemical Technology Corporation Information
12.8.2 Shanghai Theorem Chemical Technology Business Overview
12.8.3 Shanghai Theorem Chemical Technology β-nicotinamide Riboside Chloride Product Models, Descriptions and Specifications
12.8.4 Shanghai Theorem Chemical Technology β-nicotinamide Riboside Chloride Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Shanghai Theorem Chemical Technology Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 β-nicotinamide Riboside Chloride Industry Chain
13.2 β-nicotinamide Riboside Chloride Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 β-nicotinamide Riboside Chloride Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 β-nicotinamide Riboside Chloride Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 β-nicotinamide Riboside Chloride Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global β-nicotinamide Riboside Chloride Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
List of Tables
 Table 1. Global β-nicotinamide Riboside Chloride Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global β-nicotinamide Riboside Chloride Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global β-nicotinamide Riboside Chloride Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global β-nicotinamide Riboside Chloride Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global β-nicotinamide Riboside Chloride Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global β-nicotinamide Riboside Chloride Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (kg)
 Table 7. Global β-nicotinamide Riboside Chloride Sales by Region (2020-2025) & (kg)
 Table 8. Global β-nicotinamide Riboside Chloride Sales by Region (2026-2031) & (kg)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global β-nicotinamide Riboside Chloride Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (kg)
 Table 11. Global β-nicotinamide Riboside Chloride Production by Region (2020-2025) & (kg)
 Table 12. Global β-nicotinamide Riboside Chloride Production by Region (2026-2031) & (kg)
 Table 13. Global β-nicotinamide Riboside Chloride Sales by Manufacturers (2020-2025) & (kg)
 Table 14. Global β-nicotinamide Riboside Chloride Sales Share by Manufacturers (2020-2025)
 Table 15. Global β-nicotinamide Riboside Chloride Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global β-nicotinamide Riboside Chloride Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 18. Global β-nicotinamide Riboside Chloride by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in β-nicotinamide Riboside Chloride as of 2024)
 Table 19. Global β-nicotinamide Riboside Chloride Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 20. Global β-nicotinamide Riboside Chloride Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/kg)
 Table 21. Key Manufacturers β-nicotinamide Riboside Chloride Manufacturing Base and Headquarters
 Table 22. Global β-nicotinamide Riboside Chloride Market Concentration Ratio (CR5 and HHI)
 Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 25. Global β-nicotinamide Riboside Chloride Sales by Type (2020-2025) & (kg)
 Table 26. Global β-nicotinamide Riboside Chloride Sales by Type (2026-2031) & (kg)
 Table 27. Global β-nicotinamide Riboside Chloride Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global β-nicotinamide Riboside Chloride Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global β-nicotinamide Riboside Chloride ASP by Type (2020-2031) & (US$/kg)
 Table 30. Technical Specifications by Key Product Type
 Table 31. Global β-nicotinamide Riboside Chloride Sales by Application (2020-2025) & (kg)
 Table 32. Global β-nicotinamide Riboside Chloride Sales by Application (2026-2031) & (kg)
 Table 33. β-nicotinamide Riboside Chloride High-Growth Sectors Demand CAGR (2024-2031)
 Table 34. Global β-nicotinamide Riboside Chloride Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global β-nicotinamide Riboside Chloride Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global β-nicotinamide Riboside Chloride ASP by Application (2020-2031) & (US$/kg)
 Table 37. Top Customers by Region
 Table 38. Top Customers by Application
 Table 39. North America β-nicotinamide Riboside Chloride Growth Accelerators and Market Barriers
 Table 40. North America β-nicotinamide Riboside Chloride Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 41. North America β-nicotinamide Riboside Chloride Sales (kg) by Country (2020 VS 2024 VS 2031)
 Table 42. Europe β-nicotinamide Riboside Chloride Growth Accelerators and Market Barriers
 Table 43. Europe β-nicotinamide Riboside Chloride Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Europe β-nicotinamide Riboside Chloride Sales (kg) by Country (2020 VS 2024 VS 2031)
 Table 45. Asia-Pacific β-nicotinamide Riboside Chloride Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Asia-Pacific β-nicotinamide Riboside Chloride Sales (kg) by Country (2020 VS 2024 VS 2031)
 Table 47. Asia-Pacific β-nicotinamide Riboside Chloride Growth Accelerators and Market Barriers
 Table 48. Southeast Asia β-nicotinamide Riboside Chloride Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Central and South America β-nicotinamide Riboside Chloride Investment Opportunities and Key Challenges
 Table 50. Central and South America β-nicotinamide Riboside Chloride Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 51. Middle East and Africa β-nicotinamide Riboside Chloride Investment Opportunities and Key Challenges
 Table 52. Middle East and Africa β-nicotinamide Riboside Chloride Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 53. GeneHarbor Corporation Information
 Table 54. GeneHarbor Description and Major Businesses
 Table 55. GeneHarbor Product Models, Descriptions and Specifications
 Table 56. GeneHarbor Capacity, Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 57. GeneHarbor Sales Value Proportion by Product in 2024
 Table 58. GeneHarbor Sales Value Proportion by Application in 2024
 Table 59. GeneHarbor Sales Value Proportion by Geographic Area in 2024
 Table 60. GeneHarbor β-nicotinamide Riboside Chloride SWOT Analysis
 Table 61. GeneHarbor Recent Developments
 Table 62. Cayman Chemical Corporation Information
 Table 63. Cayman Chemical Description and Major Businesses
 Table 64. Cayman Chemical Product Models, Descriptions and Specifications
 Table 65. Cayman Chemical Capacity, Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 66. Cayman Chemical Sales Value Proportion by Product in 2024
 Table 67. Cayman Chemical Sales Value Proportion by Application in 2024
 Table 68. Cayman Chemical Sales Value Proportion by Geographic Area in 2024
 Table 69. Cayman Chemical β-nicotinamide Riboside Chloride SWOT Analysis
 Table 70. Cayman Chemical Recent Developments
 Table 71. Stanford Advanced Materials Corporation Information
 Table 72. Stanford Advanced Materials Description and Major Businesses
 Table 73. Stanford Advanced Materials Product Models, Descriptions and Specifications
 Table 74. Stanford Advanced Materials Capacity, Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 75. Stanford Advanced Materials Sales Value Proportion by Product in 2024
 Table 76. Stanford Advanced Materials Sales Value Proportion by Application in 2024
 Table 77. Stanford Advanced Materials Sales Value Proportion by Geographic Area in 2024
 Table 78. Stanford Advanced Materials β-nicotinamide Riboside Chloride SWOT Analysis
 Table 79. Stanford Advanced Materials Recent Developments
 Table 80. Hangzhou Longshine Bio-Tech Corporation Information
 Table 81. Hangzhou Longshine Bio-Tech Description and Major Businesses
 Table 82. Hangzhou Longshine Bio-Tech Product Models, Descriptions and Specifications
 Table 83. Hangzhou Longshine Bio-Tech Capacity, Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 84. Hangzhou Longshine Bio-Tech Sales Value Proportion by Product in 2024
 Table 85. Hangzhou Longshine Bio-Tech Sales Value Proportion by Application in 2024
 Table 86. Hangzhou Longshine Bio-Tech Sales Value Proportion by Geographic Area in 2024
 Table 87. Hangzhou Longshine Bio-Tech β-nicotinamide Riboside Chloride SWOT Analysis
 Table 88. Hangzhou Longshine Bio-Tech Recent Developments
 Table 89. Haihang Industry Corporation Information
 Table 90. Haihang Industry Description and Major Businesses
 Table 91. Haihang Industry Product Models, Descriptions and Specifications
 Table 92. Haihang Industry Capacity, Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 93. Haihang Industry Sales Value Proportion by Product in 2024
 Table 94. Haihang Industry Sales Value Proportion by Application in 2024
 Table 95. Haihang Industry Sales Value Proportion by Geographic Area in 2024
 Table 96. Haihang Industry β-nicotinamide Riboside Chloride SWOT Analysis
 Table 97. Haihang Industry Recent Developments
 Table 98. Qingdao Hong Jin Chemical Corporation Information
 Table 99. Qingdao Hong Jin Chemical Description and Major Businesses
 Table 100. Qingdao Hong Jin Chemical Product Models, Descriptions and Specifications
 Table 101. Qingdao Hong Jin Chemical Capacity, Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 102. Qingdao Hong Jin Chemical Recent Developments
 Table 103. Jinan Qinmu Fine chemical Corporation Information
 Table 104. Jinan Qinmu Fine chemical Description and Major Businesses
 Table 105. Jinan Qinmu Fine chemical Product Models, Descriptions and Specifications
 Table 106. Jinan Qinmu Fine chemical Capacity, Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 107. Jinan Qinmu Fine chemical Recent Developments
 Table 108. Shanghai Theorem Chemical Technology Corporation Information
 Table 109. Shanghai Theorem Chemical Technology Description and Major Businesses
 Table 110. Shanghai Theorem Chemical Technology Product Models, Descriptions and Specifications
 Table 111. Shanghai Theorem Chemical Technology Capacity, Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 112. Shanghai Theorem Chemical Technology Recent Developments
 Table 113. Key Raw Materials Distribution
 Table 114. Raw Materials Key Suppliers
 Table 115. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 116. Milestones in Production Technology Evolution
 Table 117. Distributors List
 Table 118. Market Trends and Market Evolution
 Table 119. Market Drivers and Opportunities
 Table 120. Market Challenges, Risks, and Restraints
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources


List of Figures
 Figure 1. β-nicotinamide Riboside Chloride Product Picture
 Figure 2. Global β-nicotinamide Riboside Chloride Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. ≥99% Purity Product Picture
 Figure 4. ≥98% Purity Product Picture
 Figure 5. ≥97% Purity Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global β-nicotinamide Riboside Chloride Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Health Products
 Figure 9. Pharmaceutical Intermediates
 Figure 10. Cosmetic Additives
 Figure 11. Others
 Figure 12. β-nicotinamide Riboside Chloride Report Years Considered
 Figure 13. Global β-nicotinamide Riboside Chloride Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global β-nicotinamide Riboside Chloride Revenue (2020-2031) & (US$ Million)
 Figure 15. Global β-nicotinamide Riboside Chloride Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 16. Global β-nicotinamide Riboside Chloride Revenue Market Share by Region (2020-2031)
 Figure 17. Global β-nicotinamide Riboside Chloride Sales (2020-2031) & (kg)
 Figure 18. Global β-nicotinamide Riboside Chloride Sales (CAGR) by Region (2020-2031) (kg)
 Figure 19. Global β-nicotinamide Riboside Chloride Sales Market Share by Region (2020-2031)
 Figure 20. Global β-nicotinamide Riboside Chloride Capacity, Production and Utilization (2020-2031) & (kg)
 Figure 21. Global β-nicotinamide Riboside Chloride Production Trend by Region (2020-2031) (kg)
 Figure 22. Global β-nicotinamide Riboside Chloride Production Market Share by Region (2020-2031)
 Figure 23. Production Capacity Enablers & Constraints
 Figure 24. β-nicotinamide Riboside Chloride Production Growth Rate in North America (2020-2031) & (kg)
 Figure 25. β-nicotinamide Riboside Chloride Production Growth Rate in Europe (2020-2031) & (kg)
 Figure 26. β-nicotinamide Riboside Chloride Production Growth Rate in China (2020-2031) & (kg)
 Figure 27. β-nicotinamide Riboside Chloride Production Growth Rate in Japan (2020-2031) & (kg)
 Figure 28. Top 5 and Top 10 Manufacturers β-nicotinamide Riboside Chloride Sales Volume Market Share in 2024
 Figure 29. Global β-nicotinamide Riboside Chloride Revenue Market Share Ranking (2024)
 Figure 30. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 31. ≥99% Purity Revenue Market Share by Manufacturer in 2024
 Figure 32. ≥98% Purity Revenue Market Share by Manufacturer in 2024
 Figure 33. ≥97% Purity Revenue Market Share by Manufacturer in 2024
 Figure 34. Others Revenue Market Share by Manufacturer in 2024
 Figure 35. Type Eight Revenue Market Share by Manufacturer in 2024
 Figure 36. Type Nine Revenue Market Share by Manufacturer in 2024
 Figure 37. Global β-nicotinamide Riboside Chloride Sales Market Share by Type (2020-2031)
 Figure 38. Global β-nicotinamide Riboside Chloride Revenue Market Share by Type (2020-2031)
 Figure 39. Global β-nicotinamide Riboside Chloride Sales Market Share by Application (2020-2031)
 Figure 40. Global β-nicotinamide Riboside Chloride Revenue Market Share by Application (2020-2031)
 Figure 41. North America β-nicotinamide Riboside Chloride Sales YoY (2020-2031) & (kg)
 Figure 42. North America β-nicotinamide Riboside Chloride Revenue YoY (2020-2031) & (US$ Million)
 Figure 43. North America Top 5 Manufacturers β-nicotinamide Riboside Chloride Sales Revenue (US$ Million) in 2024
 Figure 44. North America β-nicotinamide Riboside Chloride Sales Volume (kg) by Type (2020- 2031)
 Figure 45. North America β-nicotinamide Riboside Chloride Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 46. North America β-nicotinamide Riboside Chloride Sales Volume (kg) by Application (2020-2031)
 Figure 47. North America β-nicotinamide Riboside Chloride Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 48. US β-nicotinamide Riboside Chloride Revenue (2020-2031) & (US$ Million)
 Figure 49. Canada β-nicotinamide Riboside Chloride Revenue (2020-2031) & (US$ Million)
 Figure 50. Mexico β-nicotinamide Riboside Chloride Revenue (2020-2031) & (US$ Million)
 Figure 51. Europe β-nicotinamide Riboside Chloride Sales YoY (2020-2031) & (kg)
 Figure 52. Europe β-nicotinamide Riboside Chloride Revenue YoY (2020-2031) & (US$ Million)
 Figure 53. Europe Top 5 Manufacturers β-nicotinamide Riboside Chloride Sales Revenue (US$ Million) in 2024
 Figure 54. Europe β-nicotinamide Riboside Chloride Sales Volume (kg) by Type (2020-2031)
 Figure 55. Europe β-nicotinamide Riboside Chloride Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 56. Europe β-nicotinamide Riboside Chloride Sales Volume (kg) by Application (2020-2031)
 Figure 57. Europe β-nicotinamide Riboside Chloride Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 58. Germany β-nicotinamide Riboside Chloride Revenue (2020-2031) & (US$ Million)
 Figure 59. France β-nicotinamide Riboside Chloride Revenue (2020-2031) & (US$ Million)
 Figure 60. U.K. β-nicotinamide Riboside Chloride Revenue (2020-2031) & (US$ Million)
 Figure 61. Italy β-nicotinamide Riboside Chloride Revenue (2020-2031) & (US$ Million)
 Figure 62. Russia β-nicotinamide Riboside Chloride Revenue (2020-2031) & (US$ Million)
 Figure 63. Asia-Pacific β-nicotinamide Riboside Chloride Sales YoY (2020-2031) & (kg)
 Figure 64. Asia-Pacific β-nicotinamide Riboside Chloride Revenue YoY (2020-2031) & (US$ Million)
 Figure 65. Asia-Pacific Top 8 Manufacturers β-nicotinamide Riboside Chloride Sales Revenue (US$ Million) in 2024
 Figure 66. Asia-Pacific β-nicotinamide Riboside Chloride Sales Volume (kg) by Type (2020- 2031)
 Figure 67. Asia-Pacific β-nicotinamide Riboside Chloride Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 68. Asia-Pacific β-nicotinamide Riboside Chloride Sales Volume (kg) by Application (2020-2031)
 Figure 69. Asia-Pacific β-nicotinamide Riboside Chloride Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 70. Indonesia β-nicotinamide Riboside Chloride Revenue (2020-2031) & (US$ Million)
 Figure 71. Japan β-nicotinamide Riboside Chloride Revenue (2020-2031) & (US$ Million)
 Figure 72. South Korea β-nicotinamide Riboside Chloride Revenue (2020-2031) & (US$ Million)
 Figure 73. China Taiwan β-nicotinamide Riboside Chloride Revenue (2020-2031) & (US$ Million)
 Figure 74. India β-nicotinamide Riboside Chloride Revenue (2020-2031) & (US$ Million)
 Figure 75. Central and South America β-nicotinamide Riboside Chloride Sales YoY (2020-2031) & (kg)
 Figure 76. Central and South America β-nicotinamide Riboside Chloride Revenue YoY (2020-2031) & (US$ Million)
 Figure 77. Central and South America Top 5 Manufacturers β-nicotinamide Riboside Chloride Sales Revenue (US$ Million) in 2024
 Figure 78. Central and South America β-nicotinamide Riboside Chloride Sales Volume (kg) by Type (2021-2031)
 Figure 79. Central and South America β-nicotinamide Riboside Chloride Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 80. Central and South America β-nicotinamide Riboside Chloride Sales Volume (kg) by Application (2020-2031)
 Figure 81. Central and South America β-nicotinamide Riboside Chloride Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 82. Brazil β-nicotinamide Riboside Chloride Revenue (2020-2025) & (US$ Million)
 Figure 83. Argentina β-nicotinamide Riboside Chloride Revenue (2020-2025) & (US$ Million)
 Figure 84. Middle East, and Africa β-nicotinamide Riboside Chloride Sales YoY (2020-2031) & (kg)
 Figure 85. Middle East and Africa β-nicotinamide Riboside Chloride Revenue YoY (2020-2031) & (US$ Million)
 Figure 86. Middle East and Africa Top 5 Manufacturers β-nicotinamide Riboside Chloride Sales Revenue (US$ Million) in 2024
 Figure 87. Middle East and Africa β-nicotinamide Riboside Chloride Sales Volume (kg) by Type (2021-2031)
 Figure 88. South America β-nicotinamide Riboside Chloride Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 89. Middle East and Africa β-nicotinamide Riboside Chloride Sales Volume (kg) by Application (2020-2031)
 Figure 90. Middle East and Africa β-nicotinamide Riboside Chloride Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 91. GCC Countries β-nicotinamide Riboside Chloride Revenue (2020-2025) & (US$ Million)
 Figure 92. Turkey β-nicotinamide Riboside Chloride Revenue (2020-2025) & (US$ Million)
 Figure 93. Egypt β-nicotinamide Riboside Chloride Revenue (2020-2025) & (US$ Million)
 Figure 94. South Africa β-nicotinamide Riboside Chloride Revenue (2020-2025) & (US$ Million)
 Figure 95. β-nicotinamide Riboside Chloride Industry Chain Mapping
 Figure 96. Regional β-nicotinamide Riboside Chloride Manufacturing Base Distribution (%)
 Figure 97. β-nicotinamide Riboside Chloride Production Process
 Figure 98. Regional β-nicotinamide Riboside Chloride Production Cost Structure
 Figure 99. Channels of Distribution (Direct Vs Distribution)
 Figure 100. Bottom-up and Top-down Approaches for This Report
 Figure 101. Data Triangulation
 Figure 102. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India